"10.1371_journal.pone.0068945","plos one","2013-07-25T00:00:00Z","Hélène Blons; Etienne Rouleau; Nathanaël Charrier; Gilles Chatellier; Jean-François Côté; Jean-Christophe Pages; Florence de Fraipont; Jean-Christophe Boyer; Jean Philippe Merlio; Alain Morel; Marie-Claude Gorisse; Patricia de Cremoux; Karen Leroy; Gérard Milano; L’Houcine Ouafik; Jean-Louis Merlin; Delphine Le Corre; Pascaline Aucouturier; Jean-Christophe Sabourin; Frédérique Nowak; Thierry Frebourg; Jean-François Emile; Isabelle Durand-Zaleski; Pierre Laurent-Puig; on behalf of the MOKAECM collaborative group","UMR-S775, INSERM, Paris, France; Université Paris Descartes, Paris, France; Assistance Publique Hôpitaux de Paris Department of biology, Hôpital Européen Georges Pompidou, Paris, France; Institut Curie, Paris, France; Assistance Publique Hôpitaux de Paris, Henri Mondor-Albert Chenevier Hospitals, Department of Public Health, Creteil; URCEco Ile de France, Paris, France; Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, URC Paris, France; EA4340, Université de Versailles St Quentin en Yvelines; Assistance Publique Hôpitaux de Paris Hôpital Ambroise Paré, Department of Pathology; Boulogne-Billancourt, France; INSERM U966, Université François Rabelais de Tours, Faculté de Médecine, Tours, France; Grenoble University Hospital Department of biology, Grenoble, France; Nîmes University Hospital, Department of Biochemistry, Nîmes, France; Bordeaux University Hospital Segalene Department of Tumor Biology, Pessac; Bordeaux University EA 2406, Bordeaux, France; Cancer Center Paul Papin; INSERM U892; University of Angers, Angers, France; Institut Jean Godinot, Reims, France; Assistance Publique Hôpitaux de Paris, Saint Louis Hospital, Molecular oncology unit, Department of biochemistry, Paris, France; Assistance Publique Hôpitaux de Paris Department of pathology Henri Mondor Hospital, Creteil, France; Institut Laccassagne, Nice, France; Aix-Marseille Université, Inserm-CRO2 UMR911, AP-HM, CHU Nord, Service de Transfert dOncologie Biologique, Marseille, France; Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France; Rouen University Hospital Department of surgical and molecular pathology; Inserm U1079, Rouen, France; INCa Institut National du Cancer, Boulogne-Billancourt, France; Rouen University Hospital Department of Genetics, Inserm U614, Rouen, France","† Membership of the MOKAECM collaborative group is provided in the Acknowledgments.","Hélène Blons, Etienne Rouleau, Nathanaël Charrier, Gilles Chatellier, Jean-François Côté, Jean-Christophe Pages, Florence de Fraipont, Jean-Christophe Boyer, Jean Philippe Merlio, Alain Morel, Marie-Claude Gorisse, Patricia de Cremoux, Karen Leroy, LHoucine Ouafik, Jean-Louis Merlin, Delphine Le Corre, Pascaline Aucouturier, Frédérique Nowak, Thierry Frebourg, Jean-François Emile and Isabelle Durand-Zaleski declared that they have no competing interests. Gérard Milano: Declared being a: consultant or advisory role for Roche, Merck Serono, GSK (Direct funding to Hélène Blons) Jean-Christophe Sabourin: Declared being a consultant or advisory role for Merck Serono (Direct funding to Hélène Blons) Pierre Laurent-Puig: Declared being a consultant or advisory role for Merck Serono; Amgen; Genomic Health; Sanofi; Myriad Genetics (Direct funding to Hélène Blons). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Hélène Blons","HB",25,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
